Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Elimination of alcohol follows

Zero order kinetics. ***Zero order kinetics*** - Alcohol is metabolized at a **constant rate** (approximately 7-10 grams per hour) regardless of its concentration in the body. - This occurs because the metabolic enzymes like **alcohol dehydrogenase (ADH)** become **saturated** at blood alcohol concentrations typically achieved during drinking. - A **fixed amount** of alcohol is eliminated per unit of time, not a fixed percentage. - **Clinical significance**: This explains why you cannot speed up alcohol elimination by drinking coffee or taking cold showers. *Third Order kinetics* - This kinetic order is **not typically observed** for drug elimination in biological systems. - It would imply an extremely complex relationship between concentration and elimination rate that is not seen in clinical pharmacology. *First order kinetics* - Most drugs follow **first-order kinetics**, where a **constant fraction** (percentage) of the drug is eliminated per unit of time. - This occurs when enzyme systems are **not saturated**, which is **not the case** with alcohol at typical intoxicating doses. - At very low blood alcohol concentrations (below enzyme saturation), alcohol may exhibit first-order kinetics. *Second order kinetics* - **Second-order kinetics** means the elimination rate is proportional to the **square of the drug concentration**. - This type of kinetics is **rarely relevant** for drug elimination in pharmacology.

Q: In noncompetitive antagonism, the true statement is:

Vmax decreased; Km value normal. ***Vmax decreased; Km value normal*** - In **noncompetitive antagonism**, the antagonist binds to an **allosteric site** on the enzyme, altering its conformation and reducing its efficacy regardless of substrate concentration. - This results in a **reduced maximum velocity (Vmax)** because the antagonist effectively removes some enzyme molecules from participating in catalysis, but the **affinity (Km)** of the remaining active sites for the substrate is unaffected. *Km value increased; Vmax increased* - An **increased Km value** indicates a **decreased affinity** of the enzyme for its substrate, while an **increased Vmax** implies **enhanced catalytic activity**, which is not characteristic of any type of antagonism. - This pattern would suggest an enzyme that has been modified to bind less effectively but process substrate more rapidly, which is biologically uncommon in antagonism. *No change in Vmax; Km value decrease* - A **decreased Km value** signifies an **increased affinity** of the enzyme for its substrate, meaning it takes less substrate to reach half of the maximum velocity. - No change in Vmax combined with a decreased Km value is characteristic of **reversible competitive inhibition** at high substrate concentrations, not noncompetitive antagonism. *Km value decrease; Vmax decreases* - A **decreased Km value** suggests an **increased affinity**, meaning the enzyme binds more tightly to the substrate. - This combination is not typical for an antagonist; a reduced Vmax without a change in Km is characteristic of noncompetitive antagonism, while a decreased Km would imply improved binding.

Q: A patient presents with nephrotic syndrome and hypoalbuminemia. Protein binding of which drug is not affected?

Morphine. ***Morphine*** - Morphine is a **low protein-bound drug** (<35%), meaning a significant portion circulates freely. - Therefore, even with **reduced albumin levels** in nephrotic syndrome, the free fraction available for action is not significantly altered. *Valproate* - Valproate is **highly protein-bound** (90-95%), primarily to albumin. - In conditions like nephrotic syndrome with **hypoalbuminemia**, a decreased binding capacity leads to a higher free drug fraction and increased pharmacological effect. *Diazepam* - Diazepam is also **highly protein-bound** (98%), mainly to albumin. - Like other highly bound drugs, **hypoalbuminemia** in nephrotic syndrome would increase its free fraction, potentially leading to increased side effects. *Tolbutamide* - Tolbutamide is another drug with **high protein binding** (>90%), predominantly to albumin. - Reduced albumin levels in nephrotic syndrome would result in a **higher free concentration** of tolbutamide, increasing its hypoglycemic effect and risk of adverse reactions.

Q: Which of the following cytochromes is involved in monooxygenase mediated detoxification of drugs?

Cytochrome P450. ***Cyt P 450*** - **Cytochrome P450** enzymes are a superfamily of **monooxygenases** that play a critical role in the metabolism and detoxification of a wide variety of endogenous and exogenous substances, including drugs. - They facilitate phase I reactions (e.g., **oxidation**, reduction, hydrolysis), which typically introduce or expose functional groups to make compounds more polar and easier to excrete. *Cytochrome b5* - **Cytochrome b5** is involved in various metabolic reactions, including **fatty acid desaturation** and cholesterol biosynthesis, and can sometimes interact with P450 systems but is not the primary monooxygenase for drug detoxification. - It also participates in the reduction of methemoglobin and can act as an electron donor, but its role in drug detoxification is secondary and accessory to P450. *Cytochrome c* - **Cytochrome c** is a key component of the **electron transport chain** in mitochondria, primarily involved in cellular respiration and ATP production. - It has a crucial role in **apoptosis** when released into the cytosol, but it is not directly involved in drug monooxygenase detoxification. *NADPH-cytochrome P450 reductase* - **NADPH-cytochrome P450 reductase** is an enzyme that transfers electrons from NADPH to **cytochrome P450 enzymes**, enabling their monooxygenase activity. - While essential for P450 function, it is the **reductase** (electron donor) and not the monooxygenase enzyme itself, which is Cytochrome P450.

Q: Which of the following does not penetrate intact skin?

Dexmedetomidine. ***Dexmedetomidine*** - **Dexmedetomidine** is primarily administered intravenously as a continuous infusion for sedation and analgesia, as its molecular structure and properties do not allow for significant transdermal absorption. - While some research explores its transdermal delivery, it is **not considered to penetrate intact skin effectively** for therapeutic use through this route in current clinical practice. *Nitroglycerin* - **Nitroglycerin** patches and ointments are commonly used for the transdermal delivery of the drug to treat anginal symptoms. - Its **lipophilic nature** and small molecular size allow it to readily penetrate the skin barrier and enter systemic circulation. *Clonidine* - **Clonidine** is available in transdermal patch formulations for the treatment of hypertension. - Its ability to penetrate intact skin allows for **sustained release** and systemic absorption, providing continuous blood pressure control. *Scopolamine* - **Scopolamine** is widely used in transdermal patches to prevent motion sickness. - Its **small molecular weight** and lipophilicity enable effective penetration through the skin.

Q: In case of cyanide poisoning, antidote of amyl nitrite is given. This is an example of:

Chemical antagonism. ***Chemical antagonism*** - Amyl nitrite functions by inducing the formation of **methemoglobin**, which has a higher affinity for **cyanide ions** than cytochrome c oxidase. - This effectively sequesters cyanide, rendering it unable to bind to and inhibit the **cytochrome oxidase enzyme**, thus preventing its toxic effects [3]. *Receptor antagonism* - This involves a drug binding to a **receptor** and blocking the action of an **agonist**, without activating the receptor itself [1], [2]. - Amyl nitrite does not exert its effect by binding to a specific receptor and blocking cyanide's action; instead, it directly interacts with cyanide itself. *Physical antagonism* - This type of antagonism involves a drug preventing another drug's action through a **physical property**, such as adsorption or chelation. - While there is an interaction, the formation of methemoglobin and its subsequent binding to cyanide is more precisely described as a chemical reaction rather than a simple physical interaction or adsorption. *Physiological antagonism* - This occurs when two drugs act on **different receptors** or pathways to produce **opposite physiological effects**. - Amyl nitrite does not produce an opposite physiological effect by acting on a different pathway; rather, it directly counteracts the chemical nature of cyanide.

Q: Which of the following drugs shown in the graph below has highest potency?

Drug A. ***Drug A*** - **Potency** is determined by the concentration (or dose) of a drug required to produce 50% of its maximal effect (**EC50** or **ED50**). On a dose-response curve, the drug shifted furthest to the **left** (requiring a lower dose) is the most potent. - Drug A reaches 50% of its maximum effect at the **lowest concentration** compared to Drugs B and C, indicating higher potency. *Drug B* - Drug B requires a **higher concentration** than Drug A to achieve 50% of its maximal effect, indicating it is less potent than Drug A. - While Drug B reaches the same maximal effect as Drug A, its dose-response curve is shifted to the **right** of Drug A's. *Both Drug A and Drug B* - Although both drugs reach the same **maximal efficacy**, their potencies differ significantly. - Drug A achieves this maximal effect at a much **lower dose** than Drug B. *Drug C* - Drug C not only requires a **higher concentration** to reach its maximal effect but also exhibits a **lower maximal efficacy** compared to Drugs A and B. - Both its potency and efficacy are **lower** than those of Drug A.

Q: Longest acting local anesthetic agent is -

Bupivacaine. ***Bupivacaine*** - **Bupivacaine** is the **longest-acting local anesthetic** in common clinical use, with a duration of action of **2-9 hours** (up to 12+ hours with epinephrine). - Its prolonged effect is due to **high lipid solubility** and **extensive protein binding** (95%), allowing it to remain at the nerve site for an extended period. - Widely used for **epidural anesthesia**, **spinal anesthesia**, and **peripheral nerve blocks** requiring prolonged analgesia. *Dibucaine* - Dibucaine, while theoretically long-acting, is **rarely used clinically** in modern practice. - Primarily known as a **research tool** for testing plasma pseudocholinesterase activity (dibucaine number test). - Not a standard answer for competitive medical examinations. *Procaine* - **Procaine** is a **short-acting** local anesthetic (30-60 minutes), primarily used for infiltration. - Its rapid metabolism by **plasma pseudocholinesterase** limits its duration of action. *Lidocaine* - **Lidocaine** is an **intermediate-acting** local anesthetic (1-3 hours), widely used for various procedures due to its rapid onset and moderate duration. - Its duration is significantly shorter than bupivacaine.

Q: Low apparent volume of distribution of drug indicates that:

Drug is not extensively distributed to tissue. ***Drug is not extensively distributed to tissue*** - A **low apparent volume of distribution (Vd)** suggests that the drug primarily remains in the **vascular compartment**. - This indicates **minimal binding to peripheral tissues** and less distribution into extravascular spaces. *Drug has low bioavailability* - **Bioavailability** refers to the fraction of an administered drug that reaches the **systemic circulation unchanged**. - While related to drug disposition, a low Vd does not directly imply low bioavailability; a drug can have high bioavailability but remain largely in the blood. *Drug has low efficacy* - **Efficacy** is the maximum effect a drug can produce regardless of the dose. - Vd relates to drug distribution, not its pharmacological effect or **intrinsic activity** at its target. *Drug has low half life* - The **half-life** of a drug is determined by its **volume of distribution (Vd)** and **clearance (CL)** (t½ = 0.693 × Vd / CL). - While a low Vd can contribute to a shorter half-life if clearance is high, Vd alone does not solely determine half-life; clearance also plays a significant role.

Q: Duration of action of proparacaine:

20min. ***20min*** - **Proparacaine** is a **topical ophthalmic anesthetic** widely used for procedures like **tonometry**, **foreign body removal**, and **minor ocular surgeries**. - Its **duration of action** is typically **15-20 minutes**, making **20 minutes** the most accurate answer representing the standard effective duration. - This duration provides adequate anesthesia for most diagnostic and minor procedural needs in ophthalmology. *10min* - While proparacaine may provide some anesthetic effect at **10 minutes**, this represents the **lower end** of its duration and is **not the standard cited duration** in medical literature. - Most authoritative sources cite the duration as **15-20 minutes** rather than 10 minutes. - Relying on only 10 minutes of action would be insufficient for many ophthalmic procedures. *2min* - A duration of **2 minutes** is far too short for proparacaine's clinical applications. - Although proparacaine has a **rapid onset** (20-30 seconds), its anesthetic effect persists much longer. - This duration would be inadequate for even the briefest procedures. *5min* - **5 minutes** significantly underestimates proparacaine's duration of action. - This would not provide sufficient anesthesia for most diagnostic or therapeutic ophthalmic procedures. - Clinical practice and pharmacological data support a much longer duration.

Question 1

Elimination of alcohol follows

Accepted Answer

Zero order kinetics

Answer

Third Order kinetics

Answer

First order kinetics

Answer

Second order kinetics

Question 2

In noncompetitive antagonism, the true statement is:

Accepted Answer

Vmax decreased; Km value normal

Answer

Km value increased; Vmax increased

Answer

No change in Vmax; Km value decrease

Answer

Km value decrease; Vmax decreases

Question 3

A patient presents with nephrotic syndrome and hypoalbuminemia. Protein binding of which drug is not affected?

Accepted Answer

Morphine

Answer

Valproate

Answer

Diazepam

Answer

Tolbutamide

Question 4

Which of the following cytochromes is involved in monooxygenase mediated detoxification of drugs?

Accepted Answer

Cytochrome P450

Answer

Cytochrome b5

Answer

Cytochrome c

Answer

NADPH-cytochrome P450 reductase

Question 5

Which of the following does not penetrate intact skin?

Accepted Answer

Dexmedetomidine

Answer

Nitroglycerine

Answer

Clonidine

Answer

Scopolamine

Question 6

In case of cyanide poisoning, antidote of amyl nitrite is given. This is an example of:

Accepted Answer

Chemical antagonism

Answer

Receptor antagonism

Answer

Physical antagonism

Answer

Physiological antagonism

Question 7

Which of the following drugs shown in the graph below has highest potency?

Accepted Answer

Drug A

Answer

Drug B

Answer

Both Drug A and Drug B

Answer

Drug C

Question 8

Longest acting local anesthetic agent is -

Accepted Answer

Bupivacaine

Answer

Procaine

Answer

Lidocaine

Answer

Dibucaine

Question 9

Low apparent volume of distribution of drug indicates that:

Accepted Answer

Drug is not extensively distributed to tissue

Answer

Drug has low bioavailability

Answer

Drug has low efficacy

Answer

Drug has low half life

Question 10

Duration of action of proparacaine:

Accepted Answer

20min

Answer

2min

Answer

5min

Answer

10min

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?